2Roden MM, Zaoutis TE, Buchanan WL,et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases [J]. Clin Infect Dis,2005,41:634-653. 被引量：1
3Pagano L,Girmenia C, Mele L, et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program [J]. Haematologica,2001,86:862-870. 被引量：1
4Ascioglu S,Rex JH,de Pauw B,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoetic stem cell transplants: an international consensus[J]. Clin Infect Dis, 2002,34 : 7-14. 被引量：1
5Marty EM,Cosimi L,Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem cell transplants[J]. N Engl J Med,2004,350 : 950-952. 被引量：1
6KontoyiannisDP,LionakisMS,LewisRE,et al. Zygomycosis in the era of Aspergillus-active antifungal therapy in a tertiary care cancer center: a case-control observational study of 27 recent cases[J]. J Infect Dis,2005,191:1350-1360. 被引量：1
7Francis Y, W Lee, Sherif B. Pulmonary mucormycosis: the last 30 years[J]. Arch Intern Med, 1999,159 : 1301-1309. 被引量：1
8Georgios C,Edith MM, Russell EL,et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer[J]. Clin Infect Dis,2005,41: 60-66. 被引量：1
9Spellberg B, Edwards J,Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management[J]. Clin Microbiol Rev, 2005,18: 556-569. 被引量：1
10Lagorce PC, Fabre A, Bruneel F, et al. Disseminated mucormycosis in AIDS[J]. Ann Pathol,2000,20(4):343-345. 被引量：1
